Fiche publication
Date publication
novembre 2025
Journal
Clinics and research in hepatology and gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr VUITTON Lucine
Tous les auteurs :
Amiot A, Buisson A, Gornet JM, Fumery M, Vuitton L, Juillerat P, Bourreille A, Laharie D, Bouguen G,
Lien Pubmed
Résumé
The therapeutic arsenal for treating Crohn's disease has grown rapidly, expanding to include advanced therapies with various modes of action. Over the last two decades, physicians and patients have significantly improved the treatment of Crohn's disease, setting ambitious goals. In 2024, French clinical guidelines were established through a validated process involving the adaptation of international gastroenterology societies' clinical guidelines and French consensus meetings. The French guidelines aimed to ensure the applicability of new approaches in France, taking into account specific restrictions on drug authorization and reimbursement. This position statement outlines the specificity of the French guidelines compared to other international recommendations.
Mots clés
Crohn’s disease, advanced therapy, inflammatory bowel disease, position paper
Référence
Clin Res Hepatol Gastroenterol. 2025 11 1;:102728
